ArticleCureus2023

Conversion to Curative Resection and Pathological Complete Response Following Targeted Therapies With Atezolizumab and Bevacizumab for Initially Unresectable Hepatocellular Carcinoma: A Case Report.

Taisuke Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.